Michelle LaSpaluto
Directeur Financier/CFO chez CHIMERIX, INC.
Fortune : 98 900 $ au 30/04/2024
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Michael Sherman | M | 58 | 5 ans | |
Michael Andriole | M | 51 | 5 ans | |
Martha Demski | F | 71 | 19 ans | |
Clarence Machado | M | 60 | 10 ans | |
Roy W. Ware | M | - | 17 ans | |
David Jakeman | M | 47 | 15 ans | |
Victoria Vakiener | F | 60 | 3 ans | |
Lisa Decker | M | 55 | 1 ans | |
Robert Meyer | M | 65 | 6 ans | |
Fred Middleton | M | 74 | 6 ans | |
Pratik Multani | M | 57 | 4 ans | |
Michael Alrutz | M | 54 | 12 ans | |
Joshua Allen | M | - | 3 ans | |
Odin Naderer | M | - | 10 ans | |
Thomas Riga | M | 48 | 1 ans | |
Allen Melemed | M | 60 | 4 ans | |
Caryn Barnett | F | - | 4 ans | |
Christopher L. Jordan | M | - | 2 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
George R. Painter | M | - | 12 ans | |
Timothy J. Wollaeger | M | 80 | 16 ans | |
Kenneth Moch | M | 69 | 5 ans | |
James Niedel | M | 79 | 7 ans | |
M. Berrey | M | 57 | 7 ans | |
Ronald Renaud | M | 55 | 6 ans | |
Catherine Lynch Gilliss | M | 75 | 9 ans | |
Edward F. Greissing | M | 73 | 3 ans | |
James Daly | M | 63 | 6 ans | |
John Leonard | M | 66 | 4 ans | |
Timothy Trost | M | 66 | 7 ans | |
Wende Hutton | F | 63 | - | |
Joseph T. Schepers | M | 65 | 3 ans | |
Art Pappas | M | 76 | 3 ans | |
Ernest Mario | M | 85 | - | |
Lisa Ricciardi | F | 64 | - | |
Peter N. Payne | M | 64 | 2 ans | |
Randall Lanier | M | - | 16 ans | |
Joseph F. Rutledge | M | - | - | |
Kevin Reeves | M | - | - | |
Andrew Barrett | M | - | 1 ans | |
Michelle L. Rose | M | - | 8 ans | |
Heather Knight | M | - | - | |
Roberto Guzman | M | - | - | |
Thomas A. Pitler | M | 65 | - | |
Essy Mozaffari | M | - | - | |
Linda M. Richardson | F | 60 | 5 ans | |
Jung Choi | F | 54 | 2 ans | |
Peter Young | M | 74 |
AlphaVax, Inc.
AlphaVax, Inc. Pharmaceuticals: MajorHealth Technology AlphaVax, Inc. involves in clinical-stage biopharmaceutical company. It develops vaccine technology bio products. The firm products include Alphavax and pipleline bio products. It focuses on commercial potential of its alphavaccine vector technology in cancer immunotherapy. The company was founded in 1997 and is headquartered in Durham, NC. | 7 ans |
Rodman L. Drake | M | 80 | 1 ans | |
Farah Champsi | F | 62 | 4 ans | |
William Nichols | M | 55 | 6 ans | |
Michael D. Rogers | M | 68 | 3 ans | |
Lauren Hartle | M | - |
AlphaVax, Inc.
AlphaVax, Inc. Pharmaceuticals: MajorHealth Technology AlphaVax, Inc. involves in clinical-stage biopharmaceutical company. It develops vaccine technology bio products. The firm products include Alphavax and pipleline bio products. It focuses on commercial potential of its alphavaccine vector technology in cancer immunotherapy. The company was founded in 1997 and is headquartered in Durham, NC. | 1 ans |
Statistiques
Pays | Relations | % du total |
---|---|---|
Etats-Unis | 52 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Michelle LaSpaluto
- Réseau Personnel